Relmada Therapeutics, Inc. RLMD Deferred Tax Assets, Goodwill and Intangible Assets
Deferred Tax Assets, Goodwill and Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s deferred tax assets, goodwill and intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s deferred tax assets, goodwill and intangible assets?
- Relmada Therapeutics, Inc. (RLMD) reported deferred tax assets, goodwill and intangible assets of $3.54M in Q4 2025.
- What is the long-term trend for Relmada Therapeutics, Inc.'s deferred tax assets, goodwill and intangible assets?
- Over 2 years (2023 to 2025), Relmada Therapeutics, Inc.'s deferred tax assets, goodwill and intangible assets has grown at a 16.7% compound annual growth rate (CAGR), from $2.6M to $3.54M.